NASDAQ: QNRX
Quoin Pharmaceuticals Ltd Stock Ownership - Who owns Quoin Pharmaceuticals?

Insider buying vs selling

Have Quoin Pharmaceuticals Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Dennis LangerDirector2025-10-1415,152$8.49
$128.64kBuy

1 of 1

QNRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when QNRX insiders and whales buy or sell their stock.

QNRX Shareholders

What type of owners hold Quoin Pharmaceuticals Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Stonepine Capital Management LLC4.65%3,271,100$13.74MInsider
Michael Myers0.86%602,808$2.53MInsider
Denise P. Carter0.86%602,648$2.53MInsider
Ikarian Capital LLC0.30%211,538$888.46kInstitution
Dauntless Investment Group LLC0.28%196,592$825.69kInstitution
Gordon Dunn0.21%151,077$634.52kInsider
Anthony James Culverwell0.14%100,317$421.33kInsider
Summittx Capital LP0.14%100,300$421.26kInstitution
Velan Capital Investment Management LP0.12%84,849$356.37kInstitution
Woodline Partners LP0.11%79,582$334.24kInstitution

1 of 3

QNRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
QNRX1.69%6.75%Net Buying
HOWL25.43%74.57%Net SellingNet Selling
GTBP4.47%3.34%
QNCX25.69%74.31%Net Selling
XCUR0.25%99.75%Net Selling

Quoin Pharmaceuticals Stock Ownership FAQ

Who owns Quoin Pharmaceuticals?

Quoin Pharmaceuticals (NASDAQ: QNRX) is owned by 1.69% institutional shareholders, 6.75% Quoin Pharmaceuticals insiders, and 91.57% retail investors. Stonepine Capital Management LLC is the largest individual Quoin Pharmaceuticals shareholder, owning 3.27M shares representing 4.65% of the company. Stonepine Capital Management LLC's Quoin Pharmaceuticals shares are currently valued at $14.56M.

If you're new to stock investing, here's how to buy Quoin Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.